FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Clinical and Translational Medicine2021Vol. 11(2), pp. e310–e310
Citations Over TimeTop 1% of 2021 papers
Abstract
The interplay of these four clinically relevant factors contributes to the oncogenesis of bladder cancer. FTO facilitates the tumorigenesis of bladder cancer through regulating the MALAT/miR-384/MAL2 axis in m6A RNA modification manner, which ensures the potential of FTO for serving as a diagnostic or prognostic biomarker in bladder cancer.
Related Papers
- → The microRNA‑200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2(2019)45 cited
- → Detection of activated K-ras in non-small cell lung cancer by membrane array: A comparison with direct sequencing(2007)9 cited
- → HETEROGENEOUS EXPRESSION OF ONCOGENES IN SMALL-CELL LUNG-CANCER XENOGRAFTS(1993)4 cited
- → Tumorigenesis and cell evolution(1995)
- → Progress of the relationship between aberrant p53 protein and tumorigenesis(2019)